Boiler Room: The Official Stock Market Discussion

BlaxOps

Pro
Joined
Jul 18, 2015
Messages
992
Reputation
151
Daps
1,447
Reppin
MiYaYo (Carol City)
Assist:

Shares of Outlook Therapeutics surged in premarket trading Tuesday after the biopharmaceutical company reported a pair of advances in its efforts to win U.S. Food and Drug Administration approval of its proposed treatment for wet age- related macular degeneration, or wet AMD.
Outlook shares, which closed Monday at 34 cents , were recently up 35% to 46 cents in premarket trading.
Outlook said it reached agreement with the FDA on a 90-day non-inferiority study of ONS-5010 that, if successful, would satisfy the agency's requirement for a second adequate and well-controlled trial to address issues the FDA raised last year when it rejected the Iselin, N.J. , company's initial application for the drug.
 

chineebai

Superstar
Joined
May 11, 2012
Messages
11,194
Reputation
966
Daps
30,521
Reppin
NULL
Snow looks good if it can close above 203. You can see the choppiness there today at that level. It’s a boxed range trying to get above that level.
 

chineebai

Superstar
Joined
May 11, 2012
Messages
11,194
Reputation
966
Daps
30,521
Reppin
NULL
there is a large rush of investors to ai stocks. It’s like they’re all taking a turn. Nvda and now today it’s ibm

It’s been too easy this week which means some down side risk in my experience. Take profit where you can.
 
Top